Method of treating rheumatoid arthritis with type II collagen
US5399347A · kind A · utility
64Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 1992 |
| Grant date | Mar 21, 1995 |
| Priority date | — |
| Expiry date | Sep 25, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/543
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a method and pharmaceutical formulations for the treatment of autoimmune arthritis and animal models therefore in mammals, including humans, by the oral, enteral or by-inhalation administration of whole collagen protein or biologically active peptide fragments of collagen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.